Rewriting immunity Using CRISPR

Imagine a child born without an immune system.

Not weakened, not impaired, simply absent. Every bacterium, every virus, every scent carried on the air becomes a genuine threat. This is not a metaphor; it is a disease called SCID-X, and until now, the only option offered to these children's parents has been a bone marrow transplant that does not always succeed.

Prof. Ayal Hendel of BINA, Bar-Ilan University, together with Orly Knop and Nimrod Ben-Haim from his lab, alongside a research team from Sheba Medical Center led by Prof. Arnon Nagler and Prof. Raz Somech, approached the problem from a different angle. His new research proposes a solution based on using CRISPR to correct the genetic defect directly in the patient's stem cells. Not replace. Not suppress. Correct.

In his study, published this month, Prof. Hendel tested the correction on real human cells, and succeeded. This is a critical step preceding clinical trials, and already the gap between hope and treatment is visibly narrowing. Just as significantly, Prof. Hendel's approach holds promise for a wide range of genetic diseases that, to this day, remain without an answer.

Read the full study here: https://doi.org/10.1016/j.omtn.2026.102941

#GeneTherapy #CRISPR #BINA #BioTech